Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain

Oncogene volume 20, pages 5313–5330 (2001)Cite this article

Abstract

The Latent Membrane Protein 1 (LMP-1) protein of Epstein-Barr virus (EBV) is localized in the plasma membrane of the infected cell. LMP-1 possesses a hydrophobic membrane spanning domain, and charged, intracellular amino- and carboxy-termini. Two models have been proposed for the contribution of the amino-terminus to LMP-1's function: (i) as an effector domain, interacting with cellular proteins, or (ii) as a structural domain dictating the correct orientation of transmembrane domains and thereby positioning LMP-1's critical effector domains (i.e. the carboxy-terminus). However, no studies to date have addressed directly the structural contributions of LMP-1's cytoplasmic amino-terminus to function. This study was designed to determine if LMP-1's cytoplasmic amino-terminus (N-terminus) encodes information required solely for maintenance of proper topological orientation. We have constructed LMP-1 chimeras in which the cytoplasmic N-terminus of LMP-1 is replaced with an unrelated domain of similar size and charge, but of different primary sequence. Retention of the charged amino-terminal (N-terminal) cytoplasmic domain and first predicted transmembrane domain was required for correct transmembrane topology. The absolute primary sequence of the cytoplasmic N-terminus was not critical for LMP-1's cytoskeletal association, turnover, plasma membrane patching, oligomerization, Tumor Necrosis Factor Receptor-associated factor (TRAF) binding, NF-κB activation, rodent cell transformation and cytostatic activity. Furthermore, our results point to the hydrophobic transmembrane domain, independent of the cytoplasmic domains, as the primary LMP-1 domain mediating oligomerization, patching and cytoskeletal association. The cytoplasmic amino-terminus provides the structural information whereby proper transmembrane orientation is achieved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Aviel S, Winberg G, Massucci M, Ciechanover A . 2000 J. Biol. Chem. 275: 23491–23499

  • Baichwal VR, Sugden B . 1987 J. Virol. 61: 866–875

  • Baichwal VR, Sugden B . 1988 Oncogene 2: 461–467

  • Baichwal VR, Sugden B . 1989 Oncogene 4: 67–74

  • Bankier AT, Deininger PL, Satchwell SC, Baer R, Farrell PJ, Barrell BG . 1983 Mol. Biol. Med. 1: 425–445

  • Beltzer JP, Fiedler K, Fuhrer C, Geffen I, Handschin C, Wessels HP, Spiess M . 1991 J. Biol. Chem. 266: 973–978

  • Bloss T, Kaykas A, Sugden B . 1999 J. Gen. Virol. 80: 3227–3232

  • Bonifacino J, Lippincott-Schwartz J . 1991 Curr. Opin. Cell. Biol. 3: 592–600

  • Bonifacino J, Weissman A . 1998 Annual Review of Cell. and Dev. Biol. 14: 19–57

  • Brodeur SR, Cheng G, Baltimore D, Thorley-Lawson DA . 1997 J. Biol. Chem. 272: 1977–19784

  • Clausse B, Fizazi K, Walczak V, Tetaud C, Wiels J, Tursz T, Busson P . 1997 Virology 228: 285–293

  • Devergene O, Hatzivassiliou E, Izumi KM, Kaye K, Kleijnen MF, Kieff E, Mosialos G . 1998 J. Virol. 72: 7900–7908

  • Devergne O, Hatzivassiliou E, Izumi K, Kaye K, Kleijnen M, Kieff E, Mosialos G . 1996 Mol. Cell. Biol. 16: 7098–7108

  • Eliopoulos AG, Blake SS, Floettmann JE, Rowe M, Young LS . 1999 J. Virol. 73: 1023–1035

  • Eliopoulos AG, Rickinson AB . 1998 Curr. Biol. 8: R196–R198

  • Eliopoulos AG, Young LS . 1998 Oncogene 16: 1713–1742

  • Erickson KD, Martin JM . 2000 J. Virol. 74: 1057–1060

  • Fahreus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B . 1988 Int. J. Cancer 42: 329–338

  • Fennewald S, van SV, Kieff E . 1984 J. Virol. 51: 411–419

  • Floettmann JE, Rowe M . 1997 Oncogene 15: 1851–1858

  • Floettmann JE, Ward K, Rickinson AB, Rowe M . 1996 Virology 223: 29–40

  • Fries KL, Miller WE, Raab-Traub N . 1996 J. Virol. 70: 8653–8659

  • Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D, Hammerschmidt W . 1997 EMBO J. 16: 6131–6140

  • Gratama JW, Zutter MM, Minarovits J, Oosterveer MA, Thomas ED, Klein G, Ernberg I . 1991 Int. J. Cancer 47: 188–192

  • Gross JL, Krupp MN, Rifkin DB, Lane MD . 1983 Proc. Natl. Acad. Sci. USA 80: 2276–2280

  • Haigler HT, Ash JF, Singer SJ, Cohen C . 1978 Proc. Natl. Acad. Sci. USA 75: 5025–5029

  • Hammerschmidt W, Sugden B, Baichwal VR . 1989 J. Virol. 63: 2469–2475

  • Hammerskjold M, Simurda M . 1992 J. Virol. 66: 6496–6501

  • Hartmann E, Rapoport TA, Lodish HF . 1989 Proc. Natl. Acad. Sci. USA 86: 5786–5790

  • Hatzivassiliou E, Miller WE, Raab-Traub N, Kieff E, Mosialos G . 1998 J. Immunol. 160: 1116–1121

  • Hedge R, Lingappa V . 1997 Cell 28: 575–582

  • Hedge R, Lingappa V . 1999 Trends Cell. Biol. 9: 132–137

  • Huen DS, Henderson SA, Croom-Carter D, Rowe M . 1995 Oncogene 10: 549–560

  • Izumi KM, Kaye KM, Kieff E . 1994 J. Virol. 68: 4369–4376

  • Izumi KM, Kaye KM, Kieff ED . 1997 Proc. Natl. Acad. Sci. USA 94: 1447–1452

  • Izumi KM, Kieff ED . 1997 Proc. Natl. Acad. Sci. USA 94: 12592–12597

  • Izumi KM, McFarland EC, Ting AT, Riley EA, Seed B, Kieff ED . 1999 Mol. Cell Biol. 19: 5759–5767

  • Kaye K, Izumi K, Mosialos G, Kieff E . 1995 J. Virol. 69: 675–683

  • Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E, Mosialos G . 1996 Proc. Natl. Acad. Sci. USA 93: 11085–11090

  • Kaye KM, Izumi KM, Kieff E . 1993 Proc. Natl. Acad. Sci. USA 90: 9150–9154

  • Kaykas A, Sugden B . 2000 Oncogene 19: 1400–1410

  • Kieser A, Kaiser C, Hammerschmidt W . 1999 EMBO J. 18: 2511–2521

  • Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W . 1997 EMBO J. 16: 6478–6485

  • Knutson VP, Ronnett GV, Lane MD . 1985 J. Biol. Chem. 260: 14180–14188

  • Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM . 1992 J. Biol. Chem. 34: 24157–24160

  • Liebowitz D, Kopan R, Fuchs E, Sample J, Kieff E . 1987 Mol. Cell. Biol. 7: 2299–2308

  • Liebowitz D, Mannick J, Takada K, Kieff E . 1992 J. Virol. 66: 4612–4616

  • Liebowitz D, Wang D, Kieff E . 1986 J. Virol. 58: 233–237

  • Lipp J, Dobberstein B . 1986 J. Cell. Biol. 102: 2169–2175

  • Mann KP, Staunton D, Thorley-Lawson D . 1985 J. Virol. 55: 710–720

  • Mann KP, Thorley-Lawson D . 1987 J. Virol. 61: 2100–2108

  • Martin JM, Sugden B . 1991a Cell Growth and Differentiation 2: 653–660

  • Martin JM, Sugden B . 1991b J. Virol. 65: 3246–3258

  • Martin JM, Veis D, Korsmeyer SJ, Sugden B . 1993 J. Virol. 67: 5269–5278

  • Miller G . 1985 Epstein-Barr Virus, 1 edn. Miller G (ed.) Raven Press, New York

  • Miller WE, Cheshire JL, Raab-Traub N . 1998 Mol. Cell. Biol. 18: 2835–2844

  • Mitchell T, Sugden B . 1995 J. Virol. 69: 2968–2976

  • Moorthy RK, Thorley-Lawson DA . 1993 J. Virol. 67: 1638–1646

  • Mosialos G, Birkenbach M, Yalamanchili R, Van Arsdale T, Ware C, Kieff E . 1995 Cell. 80: 389–399

  • Paine E, Scheinman RI, Baldwin Jr. AS, Raab-Traub N . 1995 J. Virol. 69: 4572–4576

  • Pallesen G, Hamilton-Dutolt SJ, Rowe M, Young IS . 1991 Lancet 337: 320–322

  • Parks GD, Lamb RA . 1991 Cell. 64: 777–787

  • Rabson M, Heston L, Miller G . 1983 Proc. Natl. Acad. Sci. USA 80: 2762–2766

  • Roberts ML, Cooper NR . 1998 Virology 240: 93–99

  • Sandberg M, Hammerschmidt W, Sugden B . 1997 J. Virol. 71: 4649–4656

  • Schlessinger J, Shechter Y, Willingham MC, Pastan I . 1978 Proc. Natl. Acad. Sci. USA 75: 2659–2663

  • Schmid SR, Spiess M . 1988 J. Biol. Chem. 263: 16886–16891

  • Spiess M, Lodish HF . 1986 Cell. 44: 177–185

  • Spiess M, Schwartz AL, Lodish HF . 1985 J. Biol. Chem. 260: 1979–1982

  • Sylla BS, Hung SC, Davidson DM, Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E, Mosialos G . 1998 Proc. Natl. Acad. Sci. USA 95: 10106–10111

  • Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH . 1990 Transplantation 49: 944–953

  • Wang D, Liebowitz D, Kieff E . 1985 Cell 43: 831–840

  • Wang D, Liebowitz D, Kieff E . 1988a J. Virol. 62: 2337–2346

  • Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E . 1988b J. Virol. 62: 4173–4184

  • Yarden Y, Ullrich A . 1988 Annu. Rev. Biochem. 57: 443

  • Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI . 1989 N. Engl. J. Med. 321: 1080–1085

Download references

Acknowledgements

The TRAF expression plasmid and anti-HA antibody HA-11 were generous gifts from Bill Sugden. The TK-lacZ reporter was the gift of Brad Olwin. This work was supported by NIH CA-64610 and AI-01537 grants to JM Martin.

Author information

Authors and Affiliations

  1. Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Box 347, Boulder, CO 80309, Colorado, USA

    William F Coffin III, Kimberly D Erickson, Marloes Hoedt-Miller & Jennifer M Martin

Authors
  1. William F Coffin III
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kimberly D Erickson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marloes Hoedt-Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jennifer M Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer M Martin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coffin III, W., Erickson, K., Hoedt-Miller, M. et al. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain. Oncogene 20, 5313–5330 (2001). https://doi.org/10.1038/sj.onc.1204689

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204689

Keywords

This article is cited by

Search

Advanced search

Quick links